Colgate-Palmolive Company (NYSE:CL) has earned an average rating of “Hold” from the eighteen brokerages that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $76.31.

Several research analysts have recently commented on CL shares. BidaskClub lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Royal Bank Of Canada reiterated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research note on Friday, June 30th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective on the stock in a research note on Tuesday, July 4th. Jefferies Group LLC raised their target price on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a report on Thursday, July 6th. Finally, Deutsche Bank AG reissued a “hold” rating and issued a $75.00 target price on shares of Colgate-Palmolive in a report on Monday, July 24th.

Shares of Colgate-Palmolive (NYSE:CL) traded up 0.61% during trading on Wednesday, hitting $72.88. 2,345,274 shares of the stock were exchanged. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.27. The stock has a market cap of $64.20 billion, a PE ratio of 27.08 and a beta of 0.81. The stock’s 50 day moving average price is $71.88 and its 200 day moving average price is $73.18.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. The firm had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. Colgate-Palmolive’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the previous year, the company earned $0.70 earnings per share. Equities research analysts predict that Colgate-Palmolive will post $2.89 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.20%. Colgate-Palmolive’s payout ratio is 59.48%.

In related news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $72.41, for a total transaction of $277,547.53. Following the transaction, the insider now owns 53,022 shares in the company, valued at $3,839,323.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP John J. Huston sold 14,000 shares of the business’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total value of $999,040.00. Following the sale, the senior vice president now directly owns 88,598 shares in the company, valued at approximately $6,322,353.28. The disclosure for this sale can be found here. Insiders have sold 217,969 shares of company stock worth $15,693,933 over the last three months. Corporate insiders own 1.02% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Pensionfund Sabic acquired a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $2,331,000. Pensionfund DSM Netherlands bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth $4,225,000. Eqis Capital Management Inc. raised its stake in shares of Colgate-Palmolive by 7.7% in the 3rd quarter. Eqis Capital Management Inc. now owns 22,199 shares of the company’s stock worth $1,617,000 after buying an additional 1,592 shares in the last quarter. Curbstone Financial Management Corp raised its stake in shares of Colgate-Palmolive by 97.2% in the 3rd quarter. Curbstone Financial Management Corp now owns 17,420 shares of the company’s stock worth $1,269,000 after buying an additional 8,585 shares in the last quarter. Finally, Griffin Asset Management Inc. bought a new stake in shares of Colgate-Palmolive in the 2nd quarter worth $771,000. 73.10% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Colgate-Palmolive Company (CL) Given Average Rating of “Hold” by Brokerages” was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/04/colgate-palmolive-company-cl-given-average-rating-of-hold-by-brokerages.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.